Cosmos Non Current Liabilities Total vs Other Current Liab Analysis
COSM Stock | USD 0.80 0.01 1.23% |
Cosmos Health financial indicator trend analysis is way more than just evaluating Cosmos Health prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cosmos Health is a good investment. Please check the relationship between Cosmos Health Non Current Liabilities Total and its Other Current Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cosmos Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.
Non Current Liabilities Total vs Other Current Liab
Non Current Liabilities Total vs Other Current Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cosmos Health Non Current Liabilities Total account and Other Current Liab. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Cosmos Health's Non Current Liabilities Total and Other Current Liab is 0.49. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Cosmos Health, assuming nothing else is changed. The correlation between historical values of Cosmos Health's Non Current Liabilities Total and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Cosmos Health are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Non Current Liabilities Total i.e., Cosmos Health's Non Current Liabilities Total and Other Current Liab go up and down completely randomly.
Correlation Coefficient | 0.49 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Non Current Liabilities Total
Other Current Liab
Most indicators from Cosmos Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cosmos Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cosmos Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.At this time, Cosmos Health's Selling General Administrative is very stable compared to the past year. As of the 29th of November 2024, Issuance Of Capital Stock is likely to grow to about 11.3 M, while Tax Provision is likely to drop 0.00.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 8.3M | 6.0M | 4.3M | 4.4M | Total Revenue | 56.2M | 50.3M | 53.4M | 33.8M |
Cosmos Health fundamental ratios Correlations
Click cells to compare fundamentals
Cosmos Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cosmos Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Current Liabilities | 28.2M | 34.8M | 29.9M | 21.7M | 24.3M | 13.5M | |
Total Stockholder Equity | (6.5M) | (4.2M) | 4.4M | 39.7M | 36.0M | 37.8M | |
Accounts Payable | 8.6M | 12.0M | 12.1M | 10.1M | 11.9M | 12.5M | |
Common Stock Shares Outstanding | 530.9K | 532.3K | 656.9K | 1.9M | 15.9M | 16.7M | |
Non Current Liabilities Total | 2.1M | 13.2M | 15.1M | 6.6M | 5.6M | 4.9M | |
Other Stockholder Equity | 13.1M | 13.7M | 38.9M | 106.6M | 122.6M | 128.8M | |
Total Liab | 30.3M | 48.0M | 45.0M | 28.4M | 30.0M | 16.8M | |
Accumulated Other Comprehensive Income | (16.3K) | 854.9K | (151.6K) | (1.1M) | (1.3M) | (1.4M) | |
Common Stock | 13.2K | 13.5K | 17.5K | 10.6K | 9.5K | 9.1K | |
Total Assets | 23.9M | 43.8M | 49.4M | 68.0M | 66.0M | 69.3M | |
Other Current Liab | 581.5K | 2.0M | 1.3M | 3.2M | 3.5M | 3.6M | |
Net Debt | 19.2M | 31.4M | 26.8M | (8.7M) | 7.4M | 7.6M | |
Cash | 38.5K | 628.4K | 286.5K | 20.7M | 3.8M | 2.8M | |
Cash And Short Term Investments | 281.9K | 851.2K | 293.2K | 20.8M | 23.9M | 25.1M | |
Liabilities And Stockholders Equity | 23.9M | 43.8M | 49.4M | 68.0M | 78.2M | 82.2M | |
Total Current Assets | 21.2M | 40.8M | 40.9M | 56.0M | 36.6M | 18.4M | |
Retained Earnings | (19.6M) | (18.8M) | (34.3M) | (66.2M) | (91.6M) | (87.1M) | |
Short Long Term Debt Total | 19.3M | 32.0M | 27.1M | 12.0M | 13.8M | 13.4M | |
Net Tangible Assets | (3.6M) | (6.7M) | (4.4M) | 3.9M | 3.5M | 3.7M | |
Non Current Assets Total | 2.7M | 3.1M | 8.6M | 12.0M | 29.4M | 30.9M | |
Non Currrent Assets Other | 702.4K | 721.9K | 915.3K | (4.5M) | 1.1M | 1.1M | |
Other Assets | 625.4K | 538.9K | 900.3K | 6.0M | 6.9M | 7.3M | |
Other Current Assets | 665.5K | 9.7M | 1.0M | 9.1M | 6.3M | 3.8M | |
Short Long Term Debt | 18.7M | 20.7M | 13.3M | 8.0M | 8.2M | 9.8M | |
Short Term Debt | 18.9M | 20.0M | 13.6M | 8.3M | 9.6M | 9.9M | |
Property Plant And Equipment Net | 1.7M | 1.8M | 1.9M | 2.9M | 13.6M | 14.3M | |
Property Plant Equipment | 1.4M | 1.7M | 1.8M | 1.9M | 2.2M | 2.3M | |
Net Receivables | 9.3M | 26.9M | 30.1M | 22.8M | 19.8M | 14.2M | |
Short Term Investments | 243.3K | 222.8K | 6.7K | 14.9K | 20.1K | 19.1K | |
Capital Lease Obligations | 633.3K | 1.1M | 1.1M | 1.1M | 1.2M | 616.7K | |
Inventory | 3.5M | 3.3M | 3.1M | 3.5M | 4.8M | 3.1M | |
Property Plant And Equipment Gross | 2.2M | 2.4M | 2.8M | 3.8M | 14.7M | 15.4M | |
Non Current Liabilities Other | 1.7M | 1.7M | 1.6M | 2.9M | 1.8M | 1.4M | |
Intangible Assets | 214.0K | 180.8K | 443.5K | 657.2K | 7.6M | 4.6M | |
Net Invested Capital | 12.2M | 27.3M | 30.4M | 50.2M | 47.3M | 29.3M | |
Net Working Capital | (7.1M) | 6.0M | 11.0M | 34.3M | 12.3M | 7.6M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cosmos Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cosmos Health. If investors know Cosmos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cosmos Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.45) | Revenue Per Share 3.733 | Quarterly Revenue Growth 0.068 | Return On Assets (0.20) | Return On Equity (0.57) |
The market value of Cosmos Health is measured differently than its book value, which is the value of Cosmos that is recorded on the company's balance sheet. Investors also form their own opinion of Cosmos Health's value that differs from its market value or its book value, called intrinsic value, which is Cosmos Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cosmos Health's market value can be influenced by many factors that don't directly affect Cosmos Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cosmos Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cosmos Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cosmos Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.